T. Verstraelen

发表

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy

K. Vernooy, A. Maass, D. Theuns, 2022, Netherlands Heart Journal.

Development and external validation of prediction models to predict implantable cardioverter-defibrillator efficacy in primary prevention of sudden cardiac death

A. Zwinderman, T. Friede, K. Vernooy, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The role of the SCN5A‐encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders

P. Volders, A. Masclee, R. T. Bekke, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort

A. Zwinderman, A. Wilde, M. Dijkgraaf, 2021, Journal of the American Heart Association.

University of Groningen The Netherlands Arrhythmogenic Cardiomyopathy Registry

R. Hauer, A. Wilde, K. Zeppenfeld, 2019 .

Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?

A. Zwinderman, Y. Pinto, H. Marquering, 2020 .

Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy

K. Vernooy, A. Maass, D. Theuns, 2022, Netherlands Heart Journal.

Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers

A. Wilde, R. D. de Boer, M. P. van den Berg, 2021, European heart journal. Cardiovascular Imaging.

Handling missing predictor values when validating and applying a prediction model to new patients

Johannes B Reitsma, Aeilko H Zwinderman, Thomas P A Debray, 2020, Statistics in medicine.

The β-angle can help guide clinical decisions in the diagnostic work-up of patients suspected of Brugada syndrome: a validation study of the β-angle in determining the outcome of a sodium channel provocation test

P. Postema, H. Tan, A. Wilde, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers–reaching the frontiers of individual risk prediction

A. Zwinderman, R. D. de Boer, M. P. van den Berg, 2021, European heart journal.

A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablation.

B. Maesen, G. Chierchia, C. de Asmundis, 2022, Revista espanola de cardiologia.

Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms.

A. Wilde, R. D. de Boer, M. P. van den Berg, 2020, JACC. Cardiovascular imaging.

The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update

R. Hauer, A. Wilde, K. Zeppenfeld, 2019, Netherlands Heart Journal.

Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del Patients

R. D. de Boer, M. Vos, T. V. van Veen, 2022, Frontiers in Cardiovascular Medicine.

Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers

Lucas Alexandre Ramos, Henk A. Marquering, Yigal M. Pinto, 2021, Comput. Biol. Medicine.

Sex-specific aspects of phospholamban cardiomyopathy: the importance and prognostic value of low-voltage ECGs.

R. D. de Boer, M. P. van den Berg, A. Wilde, 2021, Heart rhythm.

Computer versus Cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing phospholamban (PLN) p.Arg14del mutation on ECG?

A. Zwinderman, Y. Pinto, A. Wilde, 2020, Heart rhythm.

Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy

H. Calkins, M. P. van den Berg, F. Asselbergs, 2023, Netherlands Heart Journal.

Development and Validation of a Multivariable Risk Prediction Model for Sudden Cardiac Death after Myocardial Infarction (PROFID Risk Model): Study Rationale, Design and Protocol

Katherine C. Wu, G. Hindricks, G. Pontone, 2021, medRxiv.

Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers

J. D’hooge, M. P. van den Berg, F. Asselbergs, 2023, The International Journal of Cardiovascular Imaging.

The role of the SCN5A‐encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders

P. Volders, A. Masclee, J. Kruimel, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator

A. Zwinderman, A. Wilde, M. Dijkgraaf, 2017, Netherlands Heart Journal.

Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology

L. van Erven, T. Verstraelen, DOMINIC A.M.J. Theuns, 2024, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study

A. Zwinderman, P. A. van der Zwaag, A. Houweling, 2024, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.